A lot of questions, and a few answers tomorrow and in a couple of weeks. If 113 is as good as we hope, the company will be lauded for its research engine, and that will translate into a premium on the stock price which will far exceed the value of the individual products as is currently the case. The results for 113 may be transforming for the patients, the company, and hopefully for all of us who have been patiently accumulating shares for many years.
News 
Market Data 
Discover 
